irinotecan hydrochloride

Poland

Drugs containing this active substance

  • CAMPTO

    The medicinal product is used in the treatment of patients with advanced colorectal cancer (colon and rectum) in various treatment regimens, depending on the stage of the disease and previous use of other therapies.

    Form: solution for intravenous infusion, concentrate

    Active substance Dosage
    irinotecan hydrochloride 40 mg/2 ml

    ATC: L01CE02

    Manufacturer: Pfizer Service Company BV